{"id":"NCT01311895","sponsor":"Montefiore Medical Center","briefTitle":"Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone","officialTitle":"Randomized Clinical Trial Comparing Two Protocols Using IV Hydromorphone","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2011-03-10","resultsPosted":"2018-05-18","lastUpdate":"2018-05-18"},"enrollment":350,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pain"],"interventions":[{"type":"DRUG","name":"H2O","otherNames":["Dilaudid"]},{"type":"DRUG","name":"1+1","otherNames":["Dilaudid"]}],"arms":[{"label":"H2O","type":"EXPERIMENTAL"},{"label":"1+1","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare two opioid protocols (\"H2O\" and \"1+1\") for the treatment of acute severe pain in the emergency department. The investigators primary hypothesis is that the \"H2O\" protocol will be more efficacious than the \"1+1\" protocol in Emergency Department patients aged 21-64 years. The primary outcome is the proportion of patients in each arm who choose to forgo additional pain medication at 60 minutes.","primaryOutcome":{"measure":"Number of Patients With Satisfactory Pain Management at 60 Minutes","timeFrame":"60 minutes","effectByArm":[{"arm":"H2O (2 mg IV Hydromorphone)","deltaMin":112,"sd":null},{"arm":"1+1 (1 mg IV Hydromorphone + Optional 1 mg IV Hydromorphone)","deltaMin":113,"sd":null}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":166},"commonTop":["Pruritus","Nausea","Vomiting","Pulse rate <50 beats/min","Systolic blood pressure <90 mmHg"]}}